Cargando…
Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087023/ https://www.ncbi.nlm.nih.gov/pubmed/35572363 http://dx.doi.org/10.1002/ctd2.31 |
_version_ | 1784704129492320256 |
---|---|
author | Zurita‐Lizza, Christian Carlos Doreski, Pablo Alexis |
author_facet | Zurita‐Lizza, Christian Carlos Doreski, Pablo Alexis |
author_sort | Zurita‐Lizza, Christian Carlos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9087023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90870232022-05-10 Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia Zurita‐Lizza, Christian Carlos Doreski, Pablo Alexis Clin Transl Discov Letter to the Editor John Wiley and Sons Inc. 2022-02-20 2022-03 /pmc/articles/PMC9087023/ /pubmed/35572363 http://dx.doi.org/10.1002/ctd2.31 Text en © 2022 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Zurita‐Lizza, Christian Carlos Doreski, Pablo Alexis Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title | Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title_full | Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title_fullStr | Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title_full_unstemmed | Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title_short | Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia |
title_sort | potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in covid‐19 pneumonia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087023/ https://www.ncbi.nlm.nih.gov/pubmed/35572363 http://dx.doi.org/10.1002/ctd2.31 |
work_keys_str_mv | AT zuritalizzachristiancarlos potentialreversalofpulmonaryvasoplegiabyinhaledibuprofenateincovid19pneumonia AT doreskipabloalexis potentialreversalofpulmonaryvasoplegiabyinhaledibuprofenateincovid19pneumonia |